Nigeria--strategy & strength for industry

Akanmu, Olu
November 1997
Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p74
Trade Publication
Focuses on the status and the restructuring trend of the pharmaceutical industry in Nigeria. Glaxo Wellcome's restructured business; Economic conditions of Nigeria; Government policies toward business; Presence of diverse pharmaceutical companies; Sale of over-the-counter drugs; Logistics and information technology; Segmentation of the drug market. INSET: Rocky ride..


Related Articles

  • From Europe to China--a new focus. Wechsler, Jill // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p20 

    Focuses on the pharmaceutical industry in the People's Republic of China. Signing of the Mutual Recognition Agreement on pharmaceutical plant inspection between the United States and Europe; Upgrading of domestic pharmaceutical capabilities in the country; Difficulty of drug distribution in the...

  • Ethics & enterprise--industry's dilemma. Schwartz, Harry // Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p24 

    Discusses the problems faced by the pharmaceutical industry in the United States involving ethical issues and standard practices. Collapse in the diet-drug demand due to its alleged adverse reaction; Lawsuit faced by SmithKline Beecham; Pediatric drugs not properly labeled and tested; Stiff...

  • Information showcase.  // Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p85 

    Showcases products and services related to the pharmaceutical industry in the United States. Includes marketing support services; Book entitled `Contemporary Pharmacoeconomics'; Medical handbooks; Reporting services; Production services; Biotechnology support.

  • Homeopathic drugs naturally want spot in mainstream market. Magiera, Marcy; Colford, Steven W. // Advertising Age;8/31/92, Vol. 63 Issue 35, p3 

    Reports that marketers of homeopathic medicines want to write a prescription for the American mainstream and they are spending marketing dollars doing it. Remedies that treat an ailment with small doses of natural substances; Commonly available in Europe; Homeopathic marketers expect that to...

  • New drugs often not that new.  // Aging;1991, Issue 362, p44 

    Reports on a study by the Senate Special Committee on Aging that found the vast majority of new pharmaceuticals placed on the market have little or no advantage over the usually less expensive drug therapies.

  • Pharmaceutical companies.  // Business News New Jersey;1998 Book of Lists, Vol. 11, p100 

    Ranks pharmaceutical companies in New Jersey by number of employees in their payroll. Includes Johnson & Johnson; Merck & Co.; Bristol-Myers Squibb; Schering-Plough; Novartis Pharmaceuticals.

  • Merger of the medicines. Nadeau, Jean Benoit; Dionisi, Sandra // CA Magazine;Jan/Feb96, Vol. 129 Issue 1, p24 

    Discusses the impact of the changes in the health care system on the pharmaceutical industry in Canada. Increase in research and development spending; Formation of alliances or merger with other pharmaceutical or biotech companies as a means for pharmaceuticals to sustain their market share;...

  • The pharmacist is a health care expert.  // Current Health 1;May91, Vol. 14 Issue 9, p22 

    Describes the role of the pharmacist in health care. Retail pharmacists; Hospital pharmacists; Pharmacokinetics; Pharmaceutics.

  • Untitled.  // DCI;Nov93, Vol. 153 Issue 5, p8 

    Presents news items on the pharmaceutical industry. Restructuring of Japan's Kao Corp.; Death of Croda chemist Don Suddaby and W. Gwynne Thomas, former head of the Royal Pharmaceutical Society's Department of Pharmaceutical Sciences; Formation of a subsidiary of Takeda U.S.A., Inc. in Toronto,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics